Meg Jardine's Publications

• The Global Kidney Patient Trials Network and the CAPTIVATE Platform Clinical Trial Design: A Trial Protocol.

  Journal articles

  2024

  JAMA Netw Open

• Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes

  Journal articles

  2024

  Journal of the American College of Cardiology

• Vascular Endothelial Growth Factor-B Blockade with CSL346 in Diabetic Kidney Disease: A Phase 2A Randomized Controlled Trial

  Journal articles

  2024

  Journal of the American Society of Nephrology

• Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: a participant level pooled analysis of CREDENCE and CANVAS

  Journal articles

  2024

  European Heart Journal

• Bidirectional relationship between kidney disease progression and cardiovascular events in type 2 diabetes: new Insights from the CANVAS Program and CREDENCE trial

  Journal articles

  2024

  European Heart Journal

• Atrasentan in Patients with IgA Nephropathy.

  Journal articles

  2024

  N Engl J Med

• Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial

  Journal articles

  2024

  BMJ open

• Correlation of Urinary Soluble CD163 Levels With Disease Activity and Treatment Response in IgA Nephropathy

  Journal articles

  2024

  Kidney International Reports

• Canagliflozin and iron metabolism in the CREDENCE trial.

  Journal articles

  2024

  Nephrol Dial Transplant

• Risk of Relapse of Antineutrophil Cytoplasmic AntibodyAssociated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids

  Journal articles

  2024

  Arthritis and Rheumatology

• Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trial

  Journal articles

  2024

  European Journal of Heart Failure

• Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD A Meta-Analysis of CKD Progression Trials

  Journal articles

  2024

  Clinical Journal of the American Society of Nephrology

• Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial(Nature Medicine, 10.1038s41591-024-03043-1)

  Journal articles

  2024

  Nature Medicine

• Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials

  Journal articles

  2024

  The Lancet Diabetes and Endocrinology

• IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial

  Journal articles

  2024

  Nature Medicine

• Applications of SGLT2 inhibitors beyond glycaemic control

  Journal articles

  2024

  Nature Reviews Nephrology

• Timing of Cardio-Kidney Protection With SGLT2 Inhibitors: Insights From 4 Large-Scale Placebo-Controlled Outcome Trials

  Journal articles

  2024

  Circulation

• Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study.

  Journal articles

  2024

  Nephrol Dial Transplant

• Authors Reply: Dialysate Sodium and Mortality: One Size Does Not Fit All

  Journal articles

  2024

  Journal of the American Society of Nephrology

• Adherence and persistence to novel glucose-lowering medications in persons with type 2 diabetes mellitus undergoing routine care

  Journal articles

  2024

  Diabetes Research and Clinical Practice

• Authors Reply: Dialysate Sodium and Mortality: 140 mmolL at Hemodialysis Initiation by Default?

  Journal articles

  2024

  Journal of the American Society of Nephrology

• The Efficacy and Safety of Reduced-Dose Oral Methylprednisolone in High-Risk Immunoglobulin A Nephropathy

  Journal articles

  2024

  Kidney International Reports

• Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

  Journal articles

  2024

  Circulation

• 1657 Impact of cumulative fluid and sodium imbalance exposure on cause-specific mortality in hemodialysis

  Journal articles

  2024

  Nephrology Dialysis Transplantation

• Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Results of an International Randomized Controlled Trial (PEXIVAS)

  Journal articles

  2024

  American Journal of Respiratory and Critical Care Medicine

• Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial

  Journal articles

  2024

  American Heart Journal